RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Edwards Lifesciences Revenue 2024

Edwards Lifesciences Revenue

6.72 B USD

Edwards Lifesciences Dividend yield

Ticker

EW

ISIN

US28176E1082

WKN

936853

In 2024, Edwards Lifesciences's sales reached 6.72 B USD, a 11.83% difference from the 6 B USD sales recorded in the previous year.

The Edwards Lifesciences Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e10.5143,99
2028e10.0745,95
2027e8.8952,00
2026e8.0557,42
2025e7.3862,70
2024e6.7268,88
2023677,02
20225.3879,93
20215.2376,13
20204.3975,36
20194.3574,37
20183.7274,77
20173.4474,52
20162.9673,09
20152.4975,25
20142.3273,07
20132.0574,74
20121.974,15
20111.6870,82
20101.4571,78
20091.3269,80
20081.2466,10
20071.0965,34
20061.0463,97
2005162,46
20040.9360,26

Edwards Lifesciences Aktienanalyse

What does Edwards Lifesciences do?

Edwards Lifesciences Corp is a globally operating company in the field of medical technology, specializing in the development, production, and distribution of products for the treatment of heart diseases and critical illnesses. The company was founded in California in 1958 and is now one of the leading companies in the field of modern heart valve technology. The history of Edwards Lifesciences begins with its founding by Miles "Lowell" Edwards and his longtime employee Dr. Albert Starr. They recognized the need for a less invasive and more effective alternative to heart valves than the existing surgical methods. They received their first patent in 1960 and performed their first successful heart valve operation on a sheep in the same year. The first surgeries on humans took place in 1962. Edwards Lifesciences quickly expanded in the US and internationally. The business model of Edwards Lifesciences focuses on three business areas: "Transcatheter Heart Valve Systems," "Surgical Heart Valve Therapy," and "Critical Care." Each area is focused on a specific range of products and is supported by its own team of professionals. The "Transcatheter Heart Valve Systems" area has become the most important division of Edwards Lifesciences. This novel technology enables the implantation of an artificial heart valve system through minimally invasive surgical methods, without the need for an open procedure. The system consists of a foldable heart valve made of animal tissue or artificial material, which is inserted into the damaged heart through a catheter. This method is applicable to a wide range of patients and has become an important tool in the treatment of heart diseases. The "Surgical Heart Valve Therapy" business area includes implantable mechanical and biological heart valves for open surgical procedures. Edwards Lifesciences develops innovative products to meet the needs of surgical patients and doctors. The third business area, "Critical Care," offers instruments and technologies for the critical medical care of patients in intensive care units and emergency departments. The company manufactures collagen matrix products for wound care, catheter monitoring systems, and patient monitoring devices to detect potential life-threatening complications early. Over the years, Edwards Lifesciences has introduced numerous innovative products to the market that are used in medical practice. The Edwards SAPIEN Transcatheter Heart Valve System was approved in Europe in 2011 and in the US in 2012 and has since improved the lives of tens of thousands of patients. With new technologies such as the Edwards SAPIEN 3 and SAPIEN 3 Ultra platforms, the company is constantly striving to increase the effectiveness and safety of heart disease treatment. Edwards Lifesciences is headquartered in Irvine, California, and is a multinational company with locations in North America, Europe, India, and Asia. The company currently employs approximately 14,000 people worldwide and is an important pillar of the medical community. Answer: Edwards Lifesciences Corp is a global medical technology company specializing in the development, production, and distribution of products for the treatment of heart diseases and critical illnesses. It is a leader in modern heart valve technology. Edwards Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Edwards Lifesciences's Sales Figures

The sales figures of Edwards Lifesciences originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Edwards Lifesciences’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Edwards Lifesciences's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Edwards Lifesciences’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Edwards Lifesciences Stock

How much revenue did Edwards Lifesciences generate this year?

Edwards Lifesciences has achieved a revenue of 6.72 B USD this year.

How much was the turnover of the company Edwards Lifesciences compared to the previous year?

The revenue of Edwards Lifesciences has increased by 11.83% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Edwards Lifesciences?

The revenue of Edwards Lifesciences is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Edwards Lifesciences measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Edwards Lifesciences so important for investors?

The revenue of Edwards Lifesciences is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Edwards Lifesciences pay?

Over the past 12 months, Edwards Lifesciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Edwards Lifesciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Edwards Lifesciences?

The current dividend yield of Edwards Lifesciences is .

When does Edwards Lifesciences pay dividends?

Edwards Lifesciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Edwards Lifesciences?

Edwards Lifesciences paid dividends every year for the past 0 years.

What is the dividend of Edwards Lifesciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Edwards Lifesciences located?

Edwards Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Edwards Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Edwards Lifesciences from 4/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/19/2024.

When did Edwards Lifesciences pay the last dividend?

The last dividend was paid out on 4/19/2024.

What was the dividend of Edwards Lifesciences in the year 2023?

In the year 2023, Edwards Lifesciences distributed 0 USD as dividends.

In which currency does Edwards Lifesciences pay out the dividend?

The dividends of Edwards Lifesciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Edwards Lifesciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Edwards Lifesciences

Our stock analysis for Edwards Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Edwards Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.